Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Yang Wang, M.D.
CONTACT
Jie Zhang
CONTACT
Lead
Peking University Cancer Hospital & Institute
Nivolumab and Docetaxel have been approved as standard second-line treatments for non-small cell lung cancer in several countries including China and the United States.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted